MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
660.82%
Quick Ratio
660.82%
Cash Ratio
572.46%
Debt to Asset Ratio
12.52%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Property and equipment gross
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
176,232
185,470
207,637
190,055
Accounts receivable, net
11,805
8,820
6,271
3,481
Inventory
4,678
3,645
6,013
5,729
Prepaid expenses and other current assets
10,717
9,233
8,955
8,806
Total current assets
203,432
207,168
228,876
208,071
Property and equipment gross
51,956
51,471
50,478
48,108
Less accumulated depreciation and amortization
7,196
6,577
6,022
5,534
Property and equipment, net
44,760
44,894
44,456
42,574
Intangible assets, net
-
120
120
120
Operating lease right-of-use assets
1,346
1,445
1,544
376
Other non-current assets
4,550
4,285
2,175
1,299
Total assets
254,088
257,912
277,171
252,440
Accounts payable
9,051
9,649
8,114
8,540
Accrued expenses and other current liabilities
21,484
19,836
22,598
12,332
Lease liability, short term
250
162
125
159
Total current liabilities
30,785
29,647
30,837
21,031
Lease liability, long term
1,022
1,128
1,184
266
Total liabilities
31,807
30,775
32,021
21,297
Common stock, 0.001 par value 1,000,000,000 shares authorized 16,792,317 and 12,788,069 shares issued and outstanding as of june 30, 2026, and december 31, 2025, respectively and 5,883 shares to be issued as of december31, 2025
17
14
13
10
Additional paid in capital
1,158,073
1,122,315
1,100,141
1,039,212
Accumulated deficit
-935,461
-894,909
-854,715
-807,805
Accumulated other comprehensive loss
-348
-283
-289
-274
Total stockholders equity
222,281
227,137
245,150
231,143
Total liabilities and stockholders equity
254,088
257,912
277,171
252,440
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$176,232K Accounts receivable, net$11,805K Prepaid expenses andother current assets$10,717K Inventory$4,678K Property and equipmentgross$51,956K Total current assets$203,432K Property and equipment,net$44,760K Other non-currentassets$4,550K Operating leaseright-of-use assets$1,346K Less accumulateddepreciation and...$7,196K Total assets$254,088K Total liabilities andstockholders equity$254,088K Total stockholdersequity$222,281K Total liabilities$31,807K Accumulated deficit-$935,461K Accumulated othercomprehensive loss-$348K Additional paid in capital$1,158,073K Total currentliabilities$30,785K Lease liability, longterm$1,022K Common stock, 0.001 parvalue 1,000,000,000...$17K Accrued expenses andother current...$21,484K Accounts payable$9,051K Lease liability,short term$250K

Tonix Pharmaceuticals Holding Corp. (TNXP)

Tonix Pharmaceuticals Holding Corp. (TNXP)